Introduction NO in the uterus and other tissues (Geary et al., 1998; Kirsch et al., 1999) and stimulates PGI 2 production in vascular The hormonal status of a female fluctuates with each reproductive cycle and during pregnancy. Although the vascular endothelial cells (Farhat et al., 1996; Myers et al., 1996; Jun et al., 1998) . The ability of oestrogen to stimulate the producalterations during pregnancy are well documented (Gant et al., 1987; Jovanović and Jovanović, 1997, 1998) , the impact of tion of EDHF has not been studied, although EDHF production may be enhanced in pregnant rats (Bobadilla et al., 1997 ) female hormone concentrations on vascular reactivity during the reproductive cycle has not been studied extensively. Blood and guinea pigs (Keyes et al., 1998) . This suggests that basal, as well as stimulated, release of endothelium-derived pressure is lower and urinary cAMP excretion is increased in women during the luteal phase versus the follicular phase relaxing factors may fluctuate during the reproductive cycle and pregnancy. In male and female rats, relaxation to acetyl- (Chapman et al., 1997) . Thus, changes in hormone concentrations may be reflected by marked systemic vasodilatation and/ choline or carbachol in the mesenteric vascular bed is mediated with a gas mixture (95% O 2 :5% CO 2 )-saturated PSS maintained at by endothelium-derived NO (Fortes et al., 1990) and EDHF 37°C. The perfusion rate was kept constant at 5ml/min using a (Kamata et al., 1996) by the reproductive cycle or pregnancy is unknown.
The composition of PSS (in mmol/l) was: NaCl 118, KCl 4.7,
The present study was designed to evaluate the dilatation CaCl 2 2.5, KH 2 PO 4 1.2, MgSO 4 1.2, NaHCO 3 12.5, glucose 11.1.
to acetylcholine in the isolated, perfused mesenteric vascular
The pH of the PSS was maintained at 7.4 after saturation with a 95%
bed from virgin female rats at various stages of the oestrous O 2 :5% CO 2 gas mixture. Tissues were allowed to equilibrate for at cycle (oestrus, dioestrus-1, dioestrus-2 and pro-oestrus), and least 30 min before the start of all experiments. All experiments in this study involved measuring vasodilatation to in pregnant rats (gestation day 16). The contribution of the ACh in the absence, and in the presence of inhibitors of nitric oxide endothelial-derived products-NO, prostanoids and EDHF-as synthase (NOS), cyclo-oxygenase, and K ϩ channels or combinations mediators of acetylcholine-induced vascular relaxation in each of these agents. Therefore, vascular tone in the isolated, perfused group was also explored. In pregnant females, there is reduced mesenteric vascular bed was generated by continuous infusion of contraction to vasoconstrictors which is thought to be secondary CRZ, a synthetic imidazole derivative which is stable in aqueous to increased synthesis of NO and PGI 2 (Magness et al., 1992;  medium at physiological pH and produces stable tone for many hours Kim et al., 1994) and possibly EDHF (Keyes et al., 1998) .
in this preparation (Adeagbo and Triggle, 1993) .
Therefore, in the mesenteric vascular beds from cycling and
Experimental protocols
pregnant rats, (i) the ability of a selective α 1 -adrenergic agonist, cirazoline, to induce tone, and (ii) the influence of NO,
Protocol 1
prostanoids, and EDHF on this cirazoline-induced tone were
The purpose of this series of experiments was two-fold. The first was also assessed.
to determine the pressor effect of CRZ infusion and the relative modulation of this by nitric oxide synthesis inhibition with L-NA (100 µmol/l), cyclo-oxygenase inhibition with IBU (10 µmol/l) and K ϩ channel blockade with TBA (1 mmol/l). The second purpose of
Materials and methods
these experiments was to determine the influence of the oestrous Chemicals cycle and pregnancy on ACh-induced dilatation and the relative N ω -nitro-L-arginine (L-NA), tetrabutylammonium iodide (TBA), contribution of NO, prostanoids and EDHF in mediating this response. acetylcholine (ACh) bromide and ibuprofen (IBU) were purchased
The experiments were carried out in mesenteric vascular beds isolated from Sigma Chemical Co., St Louis, MO, USA. Cirazoline hydrofrom female rats at different stages of the oestrous cycle and late chloride (CRZ) was purchased from RBI/Sigma, Natick, MA, USA.
pregnancy. Ketamine was purchased from Ft Dodge (Columbus, OH, USA) and Following the equilibration period, CRZ (1 µmol/l) was added to xylazine from Butler Co. (Columbus, OH, USA). All components of the perfusion medium and remained for the entire protocol. Once the the modified Krebs solution (physiological salt solution; PSS) were developed tone plateaued, a concentration-response relationship to purchased from Sigma Chemical Co. L-NA was dissolved in PSS;
ACh was established by giving bolus injections (0.1 ml) of ACh into all other compounds were dissolved in distilled water.
the perfusion tube (10 -4 to 10 nmol). After the tissue had recovered from the highest concentration of ACh, L-NA was added to the Animals perfusion solution (PSS) and co-infused with CRZ. After 20 min, the bolus injections of ACh were repeated. IBU was then added to Virgin female Sprague-Dawley rats weighing 200-225 g (Harlan, the perfusion solution already containing CRZ and L-NA. After the Indianapolis, IN, USA) were housed in a temperature-and humiditytone reached a plateau (usually 20 min), ACh concentrations were controlled room of our Association for the Accreditation of Laboratory given for a third time. Finally, TBA was added to the perfusion Animal Care (AALAC) -approved animal care facility with a 12 h solution along with the CRZ, L-NA and IBU and again, after tone light:12 h dark light cycle and access to distilled water and rat chow had levelled off (usually 40 min), the ACh injections were repeated. ad libitum. A vaginal smear was performed daily to determine the At the end of each experiment, sodium nitroprusside (SNP, stage of oestrous cycle. Animals were monitored for at least two 10 µmol/l) was administered to assess the ability of the vessel to oestrous cycles and only those animals exhibiting regular 4 day dilate. The tissue was always allowed to return to its pre-injection oestrous cycles were used in this study. An animal was mated when pressure before another concentration of ACh or an inhibitor was her vaginal smear indicated that she was in pro-oestrous. The day given. One group of virgin rats on dioestrous day 1 and one group that spermatozoa were present in the vaginal smear was considered of pregnant rats were subjected to the protocol without the addition of day 0 of pregnancy.
L-NA, IBU or TBA to the PSS. These groups served as time controls. The increase in perfusion pressure (tone) generated by CRZ and Perfused mesenteric vascular bed any change in tone produced by L-NA, IBU and TBA were compared Female virgin rats on each day of the oestrous cycle (oestrus, dioestrusfor the different stages of oestrous cycle and the pregnant group. 1, diestrus-2, pro-oestrus) and pregnant rats on gestation day 16 were Concentration-response curves for the response to ACh were conused in these studies. Following anaesthesia with an i.p. injection structed in presence of CRZ (control), CRZ and L-NA (L-NA present), of ketamine (37.5 mg/kg) combined with xylazine (5.0 mg/kg), the CRZ, L-NA and IBU (L-NA ϩ IBU present) and CRZ, L-NA, IBU abdominal cavity was opened and the superior mesenteric artery cannuand TBA (L-NA, IBU and TBA present). lated through an incision at its confluence with the dorsal aorta. The entire mesenteric vascular bed was then flushed with heparinized
Protocol 2 The purpose of this protocol was to determine if the order in which PSS, and the small intestinal borders were trimmed off. The bed was then transferred to a warmed (37°C) chamber where it was perfused inhibitors were added to the perfusion solution affected the vascular response to ACh. In these experiments, TBA was added to the perfusion solution prior to L-NA. For this protocol, pregnant rats and virgin rats during dioestrous-1 were used since they represent the two groups with the largest difference in reproductive hormone concentrations. In isolated, perfused mesenteries from pregnant and dioestrous-1 virgin animals, CRZ (1 µmol/l) was added to the perfusion solution to induce vascular tone. Bolus injections of ACh were given at increasing concentrations (10 -4 to 10 nmol) into the perfusion tube to determine the control concentration-response relationship. The K ϩ -channel blocker TBA (1 mmol/l) was then introduced into the perfusion solution and, after a 40 min equilibration period, ACh responsiveness was re-determined. Next, the NOS inhibitor L-NA (100 µmol/l) was introduced into the suffusion solution, in addition to CRZ and TBA. After at least a 20 min equilibration period, the vascular responsiveness to ACh was tested again. SNP (10 µmol/l) was injected at the end of each experiment to assess the ability of the vessel to dilate. The tissue was always allowed to return to its pre-injection pressure before another concentration of ACh or an inhibitor was given. Concentration-response curves for ACh were constructed in presence of CRZ (control), CRZ and TBA (TBA present) and CRZ, Figure 1 . Representative tracing from a time control experiment. TBA and L-NA (TBA ϩ L-NA present).
The responsiveness to acetylcholine (ACh) was tested repeatedly in an isolated, perfused mesenteric vascular bed taken from a rat in Statistical analysis dioestrus-1. Tone was induced with cirazoline (1 µmol/l) during the Change in tone due to the addition of CRZ, L-NA, IBU or TBA to entire protocol. Segment A is analogous to the control response in the perfusion solution was expressed in mmHg. Concentration- 40 min after the last dose of ACh in segment C. Sodium Relaxation to ACh at each concentration was expressed as a percentage nitroprusside (SNP) was given as a bolus injection after the last dose of ACh. Similar results were obtained in tissues taken from of the total developed tone. Each concentration-response curve was pregnant animals. Scale of tracing is in mmHg. used to determine the concentration of ACh that gave 50% of the maximal response (EC 50 ) and the maximal response. Change in perfusion pressure, EC 50 s, and responses at each concentration of ACh were separately compared by one-way analysis of variance (ANOVA) and Newman-Keul's multiple range tests when a significant difference existed between groups. A P value Ͻ0.05 was taken as significant. Group data are reported as mean Ϯ SEM.
Results

Establishment of tissue viability over time
The ability of the isolated, perfused mesenteric vascular bed to respond to repeated applications of ACh was tested in a group of virgin (n ϭ 4) and a group of pregnant rats (n ϭ 4). In both groups, the response to ACh was identical in all four curves obtained. A representative tracing is shown in Figure 1 . group exhibited less total tone than all other groups, and the dioestrous-1 rats (Figure 4) . The addition of L-NA to the mesenteric vascular beds from pregnant rats and rats in the pro-oestrous stage are hyporesponsive to the α 1 -adrenergic agonist CRZ compared with mesenteric beds from virgin rats pregnant group developed less overall tone than the oestrous and dioestrous day 1 group. When the increase in tone to on the other days of the oestrous cycle. Second, when NOS was inhibited with L-NA, mesenteric vascular beds from L-NA was expressed as a percentage increase above the CRZinduced tone for each individual animal, that in the pregnant pregnant rats showed a higher percentage increase in perfusion pressure than those from virgin animals. Third, vasodilatation group was significantly larger than in the oestrous, dioestrous day 1 and dioestrous day 2 groups (413 Ϯ 101% for pregnant, initiated by ACh is mediated predominantly through activation of K ϩ channels, thus suggesting an important role for EDHF 284 Ϯ 78% for pro-oestrous, 95 Ϯ 29% for dioestrous day 2, 146 Ϯ 28% for dioestrous day 1, and 111 Ϯ 33% for oestrous).
in mesenteric vessels of female rats. Normal human gestation consistently leads to hypoThe addition of IBU (10 µmol/l) to the perfusion solution containing CRZ and L-NA did not cause a significant change responsiveness to the pressor effects of angiotensin II, and perhaps also other pressure stimuli (Pan et al., 1990 ; in tone. Although adding TBA (1 mmol/l) to the perfusion medium containing CRZ, L-NA and IBU caused a transient Lindheimer et al., 1992) . The refractoriness of the mesentery from pregnant rats to cirazoline observed in the present study reduction in perfusion pressure, vessel tone recovered to preapplication level without adjusting the concentration of CRZ.
is consistent with those findings. Since this effect was also seen in animals in pro-oestrus, this could be related to Effect of L-NA and/or IBU on ACh-induced relaxation the increased hormone concentrations, presumably oestrogen, during pregnancy and pro-oestrus. It was reported recently Bolus injections of ACh (0.0001-1 nmol) initiated concentration-dependent decreases in perfusion pressure of CRZ pre- (Chapman et al., 1997) that women during the luteal phase of the menstrual cycle exhibited a lower systemic arterial pressure constricted mesenteric vascular beds of all experimental groups. The response to ACh was not affected by the day of the compared with women in the follicular phase. Aortic rings from rats in pro-oestrus showed a reduction in the maximal oestrous cycle or by pregnancy (Table I) .
In the presence of L-NA, there was a significant attenuation contraction to noradrenalin and increased synthesis of dilator prostaglandins compared with aortas from rats in oestrus, of the response to ACh in the oestrous, dioestrous day 1, dioestrous day 2 and pro-oestrous groups, but maximal dioestrus or met oestrus (Zamorano et al., 1994) . Both these studies were performed when oestrogen concentrations were responses were not altered (Figure 3 ). L-NA did not alter the response to ACh in isolated, perfused mesenteric vascular beds elevated, suggesting that oestrogen could be responsible for these vascular alterations. removed from pregnant rats (Figure 3, bottom graph) . The addition of IBU to the perfusion medium did not modify AChAlthough the cardiovascular benefits of oestrogen therapy have been well documented (Mikkola et al., 1998) , the induced vasodilatation in any experimental group (Figure 3) . mechanism by which oestrogen exerts its effects on the Effect of TBA on NO/prostanoid-independent vasodilatation vasculature is not completely understood. Chronic administrato ACh tion of oestrogen has been associated with an enhanced release of NO and prostaglandins from the endothelium in both In all experimental groups, treatment with L-NA alone or in combination with IBU, to inhibit NOS and cyclo-oxygenase humans and experimental animals (Farhat et al., 1996) . In addition, oestrogen therapy has been associated with coronary respectively (Figure 3) , gave no or only partial blockade of the ACh-induced vasodilatation. Thus, the effect of a K ϩ blood flow regulation in part by up-regulating NOS activity (Gorodeski et al., 1995) . Furthermore, resistance vessels from channel antagonist TBA on vasodilator responses to ACh was tested in the presence of L-NA and IBU. TBA in the presence the mesentery of ovariectomized female rats receiving oestrogen replacement, exhibited an increase in basal, but of L-NA and IBU significantly reduced the vasodilator response of the mesenteric vascular bed to ACh in all groups (Figure 3) . not ACh-stimulated, release of endothelium-derived relaxing factors (Meyer et al., 1997) . When TBA was introduced into the perfusion solution containing CRZ prior to L-NA (protocol 2), it caused a The present study also reported a relatively higher increase in perfusion pressure in the mesenteric vascular bed from significant reduction in ACh-induced dilatation of the mesenteric vascular beds from both pregnant and virgin pregnant rats after addition of L-NA into the perfusion solution. This agrees with previous studies (Weiner et al., 1994 ; Nathan resistance vessels under isometric conditions. However, others report that ACh-induced relaxation is enhanced in mesenteric et al., 1995) reporting an increase in basal vascular NO synthesis during pregnancy. If basal release of NO is increased arteries from pregnant rats (Kim et al., 1994; Gerber et al., 1998) , and in carotid arteries from the pregnant guinea pig in pregnancy, this could explain the refractoriness to CRZ observed in the pregnant group (Molnár and Hertelendy, 1992) . (Weiner et al., 1989) . Taken together, these results suggest a divergent responsiveness to ACh between resistance and The data presented here also revealed that in the isolated perfused mesenteric vascular bed pre-constricted with CRZ, conductance vessels during pregnancy. In this study, L-NA did not change the vascular reactivity ACh-induced relaxation did not differ among pregnant and non-pregnant cycling rats. Similarly, it was reported (Yamasaki of the mesenteric vascular bed to ACh in the pregnant group although it caused a small but statistically significant inhibition et al., 1996) that neither ACh-induced relaxation nor basal NO biosynthesis is increased in the late pregnant rat femoral in the cycling virgin groups. This suggests two possibilities: oestrous groups is caused by an increase in vascular smooth muscle NO activity rather than endothelium-released NO. In the human uterine artery, L-arginine-induced relaxation is mediated by non-endothelial NO production (Jovanović et al., 1994b) . Another possible reason is that since the portion of the ACh-induced dilation in this vascular bed attributable to NO is so small, it may not have been possible to detect any increase in the relaxation to ACh with the number of preparations reported here. In fact, although not statistically significant, at two points of the ACh concentration-response curve (0.001 and 0.01 nmol), the response of the pregnant group does appear larger than the virgin groups (data not shown).
In an earlier study (Gant et al., 1987) , it was found that inhibition of cyclo-oxygenase restored the vascular refractoriness to angiotensin II in pregnant women, suggesting that prostanoids are a pivotal mediator of vascular reactivity during pregnancy. In our study, ibuprofen did not alter ACh-induced relaxation in the presence of L-NA, demonstrating that cyclooxygenase products are not major contributors to ACh-induced dilatation in the female mesenteric vascular bed. This agrees with previous findings (Meyer et al., 1997) in which AChinduced dilatation was not affected by cyclo-oxygenase inhibition in isolated mesenteric arterioles from ovariectomized or oestrogen-treated rats. Similarly, in recent studies using a double-perfused mesentery preparation from Wistar Kyoto and spontaneously hypertensive male rats, it was shown that the cyclo-oxygenase pathway was not implicated in the vasodilatation induced by ACh (Le Marquer-Domagala and Finet, 1997) . These studies all indicate that, at least in the mesenteric vascular bed, prostanoids are not involved in the vascular response to ACh.
In all virgin and pregnant groups the majority of the ACh- NO, non-prostanoid factor, which dilates by opening K ϩ channels. Although the EDHF has yet to be identified, it is known to promote vasodilatation by activating K ϩ -channels, (i) that during late pregnancy in rats, there is a shift to some mediator other than NO for the ACh vasodilator response in resulting in smooth muscle cell membrane hyperpolarization. Therefore, the use of K ϩ -channel blockers or varying the mesentery; or (ii) that there is an up-regulation of NOS in the mesenteric vessels from the pregnant rat. If the latter were extracellular K ϩ has been used consistently to demonstrate EDHF-mediated relaxation (Adeagbo and Triggle, 1993 ; true, the concentration of L-NA used in the present study may not have been sufficient to inhibit the up-regulated NOS. McCulloch and Randall, 1998) . TBA has been shown to block EDHF-mediated responses in many vessels, including coronary Thus, in the isolated, perfused mesenteric vascular bed, NO activity appeared to be up-regulated in pregnancy and possibly artery (Nakashima et al., 1997; Popp et al., 1998; Kaw and Hecker, 1999) , omental arteries (Ohlmann et al., 1997 ) and on pro-oestrus. This raises the question of why we did not observe an increase in the relaxation to ACh in these carotid artery (Dong et al., 1997) . This last finding agrees with that from a recent study preparations. The lack of effect of pregnancy on ACh-induced dilation has been observed in other vessels such as the renal (McCulloch and Randall, 1998) in which data from female rats on different oestrous cycle days were pooled and the and uterine arteries (Jovanović et al., 1994a; Kim et al., 1994) . One possible reason for this seeming dichotomy is that the responsiveness to carbachol in the isolated, perfused mesenteric vascular bed investigated. As in the present study, these apparent increase in NO activity in the pregnant and pro-
